These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23001712)

  • 21. Regression stage senile plaques in the natural course of Alzheimer's disease.
    Oide T; Kinoshita T; Arima K
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of inflammation in Alzheimer's disease.
    Tuppo EE; Arias HR
    Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review: inflammatory process in Alzheimer's disease, role of cytokines.
    Rubio-Perez JM; Morillas-Ruiz JM
    ScientificWorldJournal; 2012; 2012():756357. PubMed ID: 22566778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
    Geylis V; Steinitz M
    Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy for Alzheimer's disease.
    McGeer PL; McGeer E
    Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
    Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
    El Khoury J; Luster AD
    Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroinflammatory perspectives on the two faces of Alzheimer's disease.
    Eikelenboom P; van Gool WA
    J Neural Transm (Vienna); 2004 Mar; 111(3):281-94. PubMed ID: 14991455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy of Alzheimer's disease: current and future trends.
    Geldenhuys WJ; Darvesh AS
    Expert Rev Neurother; 2015 Jan; 15(1):3-5. PubMed ID: 25481975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for Alzheimer's disease.
    Farlow MR; Brosch JR
    Neurol Clin; 2013 Aug; 31(3):869-78. PubMed ID: 23896510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The therapeutic potential of the endocannabinoid system for Alzheimer's disease.
    Karl T; Cheng D; Garner B; Arnold JC
    Expert Opin Ther Targets; 2012 Apr; 16(4):407-20. PubMed ID: 22448595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.
    Liu YH; Zeng F; Wang YR; Zhou HD; Giunta B; Tan J; Wang YJ
    Drug Discov Today; 2013 Dec; 18(23-24):1212-20. PubMed ID: 23954180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation, immunity, and Alzheimer's disease.
    Town T
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):129-31. PubMed ID: 20205648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the Interplay Between Aging and Neuroinflammation Modulate Alzheimer's Disease Clinical Phenotypes? A Clinico-Pathological Perspective.
    Taipa R; Sousa AL; Melo Pires M; Sousa N
    J Alzheimers Dis; 2016 May; 53(2):403-17. PubMed ID: 27176075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy?
    Trepanier CH; Milgram NW
    J Alzheimers Dis; 2010; 21(4):1089-99. PubMed ID: 21504126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation in Alzheimer's disease wanes with age.
    Hoozemans JJ; Rozemuller AJ; van Haastert ES; Eikelenboom P; van Gool WA
    J Neuroinflammation; 2011 Dec; 8():171. PubMed ID: 22152162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old.
    Katsel P; Haroutunian V
    Dialogues Clin Neurosci; 2019 Mar; 21(1):7-19. PubMed ID: 31607776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.